Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

Abstract Introduction Given the challenges concerning the differential diagnosis of dementia, we investigated the possible added value of monoaminergic compounds to the standard cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. Particularly, regarding the AD versus dementia with Le...

Full description

Bibliographic Details

Published in:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Main Authors:	Jana Janssens, Yannick Vermeiren, Erik Fransen, Tony Aerts, Debby Van Dam, Sebastiaan Engelborghs, Peter P. De Deyn
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Subjects:	MHPG Biomarkers Alzheimer's disease Dementia with Lewy bodies Monoamines Diagnostic accuracy
Online Access:	https://doi.org/10.1016/j.dadm.2018.01.002